These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes. Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension. Johnson SR; Swiston JR; Granton JT J Rheumatol; 2008 Aug; 35(8):1584-90. PubMed ID: 18597400 [TBL] [Abstract][Full Text] [Related]
7. Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis. Vandecasteele E; De Pauw M; De Keyser F; Decuman S; Deschepper E; Piette Y; Brusselle G; Smith V Int J Cardiol; 2016 Jun; 212():265-73. PubMed ID: 27057932 [TBL] [Abstract][Full Text] [Related]
8. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand. Foocharoen C; Nanagara R; Kiatchoosakun S; Suwannaroj S; Mahakkanukrauh A Int J Rheum Dis; 2011 Aug; 14(3):282-9. PubMed ID: 21816025 [TBL] [Abstract][Full Text] [Related]
14. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity. Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682 [TBL] [Abstract][Full Text] [Related]
15. [The clinical characteristics of systemic sclerosis-related pulmonary arterial hypertension]. Wang H; Tian Z; Liu Y; Li M; Wang Q; Zeng X; Fang Q Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):390-3. PubMed ID: 25146407 [TBL] [Abstract][Full Text] [Related]
16. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis. Moinzadeh P; Bonella F; Oberste M; Weliwitage J; Blank N; Riemekasten G; Müller-Ladner U; Henes J; Siegert E; Günther C; Kötter I; Pfeiffer C; Schmalzing M; Zeidler G; Korsten P; Susok L; Juche A; Worm M; Jandova I; Ehrchen J; Sunderkötter C; Keyßer G; Ramming A; Schmeiser T; Kreuter A; Lorenz HM; Hunzelmann N; Kreuter M Chest; 2024 Jan; 165(1):132-145. PubMed ID: 37582424 [TBL] [Abstract][Full Text] [Related]
17. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Humbert M; Yaici A; de Groote P; Montani D; Sitbon O; Launay D; Gressin V; Guillevin L; Clerson P; Simonneau G; Hachulla E Arthritis Rheum; 2011 Nov; 63(11):3522-30. PubMed ID: 21769843 [TBL] [Abstract][Full Text] [Related]
18. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort. Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience. Demir N; Şahin A; Küçükşahin O; Kayacan O; Dinçer İ; Sayın T; Karnak D; Turgay M Heart Lung Circ; 2014 Jul; 23(7):667-73. PubMed ID: 24613044 [TBL] [Abstract][Full Text] [Related]